As with all GLP-1 medications, side effects typically flare briefly after each dose increase and settle within 37 days
Meanwhile, Indias obesity drug market could grow to 8,000 crore by 2030 from roughly 1,500 crore today, as per Pharmarack
One such innovative treatment we provide is Ozempic, a GLP-1 receptor agonist initially developed to help individuals with Type 2 diabetes manage their blood sugar
Comirnaty (tozinameran) Disease area(s): Vaccines/infectious diseases Manufacturer(s): Pfizer/BioNTech 2024 Sales (USD ): $7.79 billion Why it sold so well: In 2024, Pfizers COVID-19 vaccine, Comirnaty, generated $3.38 billion in revenue during the fourth quarter, surpassing expectations by approximately $280 million, and $5.35 billion for the year
Its best-practice table pairs a smaller gauge and shorter length with less tissue damage and pain, on the reasoning that reaction severity tracks with how much trauma the needle causes
Leave a Comment Be the first to comment.